← FDA Drug Approvals (Drugs@FDA)
IRON SUCROSE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-08-08
Drug application
- FDA Application #
ANDA212559- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IRON SUCROSE
- Generic name
- IRON SUCROSE
- Active ingredients
- IRON SUCROSE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2025-08-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown